Anti-cancer drugs such as cisplatin and doxorubicin are effectively used more than radiotherapy. Cisplatin is a chemotherapeutic drug, used for treatment of various forms of cancer. However, it has side effects such as ototoxicity and nephrotoxicity. Cisplatin-induced nephrotoxicity increases tubular damage and renal dysfunction. Consequently, we investigated the beneficial effect of cynaroside on cisplatin-induced kidney injury using HK-2 cell (human proximal tubule cell line) and an animal model. Results indicated that 10 µM cynaroside diminished cisplatin-induced apoptosis, mitochondrial dysfunction and caspase-3 activation, cisplatin-induced upregulation of caspase-3/MST-1 pathway decreased by treatment of cynaroside in HK-2 cells. To confirm the effect of cynaroside on cisplatin-induced kidney injury in vivo, we used cisplatin exposure animal model (20 mg/kg, balb/c mice, i.p., once a day for 3 days). Renal dysfunction, tubular damage and neutrophilia induced by cisplatin injection were decreased by cynaroside (10 mg/kg, i.p., once a day for 3 days). Results indicated that cynaroside decreased cisplatin-induced kidney injury in vitro and in vivo, and it could be used for improving cisplatin-induced side effects. However, further experiments are required regarding toxicity by high dose cynaroside and caspase-3/ MST-1-linked signal transduction in the animal model.
INTRODUCTION
Cynaroside is a flavone, a flavonoid-like compound. It is known under various names (Luteolin-7-O-glucoside, Luteoloside, Cinaroside), commonly found in Lonicera japonica Thunb. and Angelica keiskei. According to recent studies, cynaroside has absorbed in gastrointestinal tract, and it has an anti-oxidant effect, inhibiting lipid and protein oxidation (1) (2) (3) (4) . However, the protective effect of cynaroside on cisplatin-induced nephrotoxicity has not been elucidated.
Incidence of cancer mortality has increased with pollution and diet, despite development of medical standards and life (5) . Cisplatin (cis-diamminedichloroplatium [II] ) an anti-cancer drug, is commonly used in cancer treatment. However, despite wide use of cisplatin for cancer treatment, there are restrictions in using this anti-cancer drug because it may induce cardiotoxicity and nephrotoxicity (6) . Cisplatin is eliminated from the body through filtration and secretions in kidneys, but it may cause nephrotoxicity if excessively used for cancer treatment (7) (8) (9) . Thus, research on medicinal plants and active ingredients isolated from resource plants are needed for reducing negative side effects of chemotherapy.
MST (mammalian sterile 20-like kinase), a protein kinase (10) , is involved in various cellular processes, such as transcriptional regulation, cell death, signal transduc-tion, and post-translational modification (11, 12) . The MST protein family are common proteins expressed in almost all tissues. MST-1 was mostly expressed in kidneys. It was proteolytically activated caspase protein during apoptosis, and activated by apoptotic stimulation as well as other stress responses. MST-1 activation requires phosphorylation and caspase-3 mediated cleavage, resulting in autophosphorylation at Thr 183 and Thr 187 within its catalytic domain, leading to initiation of cell death including DNA fragmentation and chromatin condensation (13) (14) (15) . Therefore, this study focused on the role of cynaroside under the condition of cisplatin exposure in HK-2 cell (human proximal tubule cell line). Thus, this study investigated 1) the relationship between cynaroside and caspase-3/MST-1 signal pathway in cisplatin-induced nephrotoxicity, 2) the protective effect of cynaroside on cisplatin-induced nephrotoxicity in vivo model.
MATERIALS AND METHODS

Chemicals. Cynaroside isolated from Lonicera japonica
Thunb. (CAS 5373-11-5, purity: 97.5%) was purchased from Biopurify (Chengdu, Sichuan, China). Cisplatin (479306) and was purchased from Sigma Aldrich (St. Louis, MO, USA). Cisplatin fully dissolved in 0.9% NaCl, was stored at −20 o C by protection from light.
Cell culture. HK-2 cells (human kidney proximal tubule cell) obtained from the Korean Cell Line Bank (KCLB, Seoul, Korea), were grown at 37 o C in 5% CO 2 in Roswell Park Memorial Institute medium (RPMI 1640 medium) with 10% FBS (fetal bovine serum) and 1% penicillin/streptomycin. The media was changed every other day. Passaged cells were plated to yield near-confluent cultures at the end of experiments.
Animals. Male BALB/c mice (6 weeks of age) purchased from Samtako (Osan, Korea) were separated into 3 groups (Control; n = 7, Cisplatin; n = 7, Cisplatin + cynaroside; n = 7). Mice were administrated cisplatin (20 mg/kg, i.p., once a day, 3 days). After cisplatin administration for 30 min, cisplatin + cynaroside group was administrated with cynaroside (10 mg/kg, i.p., once a day, 3 days).
Measurement of cell viability. Cell viability measured by using Celliter 96
® aqueous one solution cell proliferation assay (Promega, Fitchburg, WI, USA), according to manufacturer's instructions. Cells cultured in 96 well plate were incubated with various concentration of cynaroside (10, 20, 40 , and 80 μM) or after treatment with 20 μM cisplatin for 30 min, HK-2 cells were treated with cynaroside (10, 20, 40 Caspase-3 activity assay. Caspase-3 activity assay conducted by using Caspase-3 colorimetric detection kit (Enzo), according to manufacturer's instructions. HK-2 cells were lysed in RIPA cell lysis buffer 2 (Enzo) containing Pierce TM protease and phosphatase inhibitor mini tablets (Thermo) for 1 hr. Cell lysate was centrifuged for 10 min at 13,000 rpm at 4 o C, protein levels were quantified using Bradford procedure. Whole cell lysate (20 μg) used to caspase-3 activity assay. Blood cell analysis. Blood cells analysis conducted using IDEXX Procyte DX gematology analyzer (IDEXX, Westbrook, ME, USA) according to manufacturer's instructions. Whole blood was collected in BD Vactutainer TM glass blood collection tube with K 3 EDTA (Thermo), and used for blood cell analysis. Imaging was indicated lymphocyte (blue color), neutrophil (pink color), and monocyte (red color).
Blood chemistry analysis. Blood chemistry analysis conducted using FUJI DRI-CHEM 4000i (Fujifilm, Tokyo, Japan), according to manufacturer's instructions. Whole blood collected in BD Vacutainer TM SST tube (Thermo), incubated at room temperature for 10 min. Blood centrifuged for 10 min at 4,000 rpm at 4 o C, separated serum samples were used for blood chemistry analysis (BUN, blood urine nitrogen; Cre, creatinine).
Hematoxylin & Eosin staining. Kidneys were harvested from mice, fixed in 10% NBF overnight and then paraffinized with paraffin, xylene, and diluted ethanol. Paraffinized kidney samples were cut into 4 μM using microtome (Leica, Wetzlar, Germany). Paraffin sections were deparaffinized with xylene (Sigma Aldrich) and hydrated with water and diluted ethanol, and used for hematoxylin & eosin staining.
Statistical analysis.
Results were expressed as mean ± the SEM. Values are mean ± SEM of three independent experiments. For group comparisons, statistical analysis was conducted using one-way ANOVA by SPSS (SPSS Inc., IL, USA), followed by the Tukey post hoc test and Duncan's multiple rage test, were used. A value of p < 0.05 was considered significant.
RESULTS
Cynaroside treatment reduces cisplatin-induced cell death and DNA fragmentation in HK-2 cell. To confirm the protective effect of cynaroside in cisplatin-induced cell death, HK-2 cells (human proximal tubule cell) were pretreated with various concentrations (1.25, 2.5, 5, and 10 μM) for 30 min. After pre-treatment, cells were treated with 20 μM cisplatin for 24 hr. Cell viability was measured by MTS assay, HK-2 cell death was reduced by pretreatment of 5 and 10 μM cynaroside (Fig. 1A) . As shown in Fig. 1A , cell viability significantly decreased by 20 μM cisplatin at 75.8 ± 1.0%, but recovered by 10 μM cynaroside at 86.6 ± 3.0%. Next, Tunel assay was conducted to reveal DNA fragmentation during the cell death process, visualized by Tunel assay (Fig. 1B) . The Tunel positive signal increased by treatment of 20 μM cisplatin, but decreased by pre-treatment of 10 μM cynaroside. This result indicated that cisplatin-induced cell death was diminished by pre-treatment of 10 μM cynaroside in HK-2 cells.
Cynaroside treatment attenuates cisplatin-induced apoptosis and mitochondrial dysfunction in HK-2 cell. To reveal the inhibition effect of apoptosis and mitochondrial dysfunction during cell death, cells were pre-treated with 10 μM cynaroside for 30 min. After pre-treatment, cells were treated with 20 μM cisplatin for 24 hr. Apoptotic cell death was measured by Annexin V/PI staining. Under these condition, dysfunction of mitochondrial membrane potential (MMP) determined by JC-1 staining. As shown in Fig. 2A , apoptotic cell death increased by 20 μM cisplatin at 24.12 ± 2.6%. but was diminished by 10 μM cynaroside at 13.15 ± 2.4% ( Fig. 2A) . MMP is indicated by decrease in the red/green fluorescence intensity ratio, the green color shift is due to formation of red fluorescence J-aggregates. Results indicated that red fluorescence decreased by 20 μM cisplatin at 49.26 ± 5.8% than control group (red fluorescence; 76.41 ± 3.8%), and recovered by 10 μM cynaroside at 74.47 ± 3.5% (Fig. 2B) . Collectively, apoptotic cell death and mitochondrial dysfunction were diminished by pre-treatment of cynaroside on cisplatin-induced cell death in HK-2 cell.
Cisplatin-induced caspase-3/MST-1 signal is attenuated by cynaroside treatment. Amin et al. (13) reported that MST-1 interacted with caspase-3 protein during apoptotic cell death in mammalian cell. It has also been reported that MST-1 is mostly expressed in kidney, closely associated with apoptotic cell death (11) . In this study, 20 μM cisplatin treatment increased Caspase-3/MST-1 signaling pathway, decreased by pre-treatment with 10 μM cynaroside (Fig. 3A) . Caspase-3 activity increased by 20 μM cisplatin at 134.40 ± 1.5% than the control group, but was diminished with pre-treatment of 10 μM cynaroside at 110.70 ± 2.9% (Fig. 3B) . In summary, cisplatininduced apoptosis via caspase-3/MST-1 signaling pathway and caspase-3 activation was abolished by cynaroside treatment, suggesting that cynaroside may be inhibited caspase-3/MST-1 signaling during cisplatin-induced cell death in HK-2 cell.
Effects of cynaroside on cisplatin-induced nephrotoxicity on blood analysis. To evaluate the protective effect of cynaroside on cisplatin-induced nephrotoxicity in vivo, we used the cisplatin nephrotoxicity model (20 mg/kg, balb/c mice, i.p., once a day for 3 days). In accordance with results from HK-2 cells, cisplatin administration increased blood neutrophils (Fig. 4A) . BUN (blood urine nitrogen) and Cre (creatinine) in serum increased by cis- (Fig. 4B) . As shown Fig. 4A , neutrophils in whole blood increased by cisplatin administration at 77.47 ± 4.6% on white blood cells than the control group (blood neutrophil; 14.12 ± 0.7%), and recovered by cynaroside administration at 32.72 ± 3.6% on white blood cells. Serum level of BUN and Cre increased by cisplatin administration (cisplatin group; BUN, 124.90 ± 5.2 mg/dL; Cre, 1.57 ± 0.1 mg/dL), and decreased by cynaroside administration (cisplatin + cynaroside group; BUN, 26.57 ± 1.6 mg/dL; Cre, 0.52 ± 0.1 mg/dL). Collectively, serum level of BUN and Cre increased by cisplatin decreased by cyanroside administration in balb/c mice.
Cynaroside reduces cisplatin-induced nephrotoxicity in vivo model. Comparing the histological feature in different groups, the renal cortex of mice revealed a tubular histological structure using H&E staining (Fig. 5A) . In cisplatin administrated mice (cisplatin group), histological examination revealed loss of brush border, and desquamation of epithelial cells in renal tubular epithelium. In contrast, degenerative changes such as loss of brush border markedly recovered by cynaroside administration (cisplatin + cynaroside group) in renal tissue. Cisplatin administration increased Tunel positive signal in renal tissue, in contrast, administration of cynaroside in cisplatin-injected mice reduced Tunel positive signal (Fig. 5B) .
DISCUSSION
Pathogenesis of nephrotoxicity by cisplatin was associated with cell death and inflammation (16) (17) (18) . Apoptotic cell death is an important process in cisplatin-induced nephrotoxicity, MST-1 involved in cell death of cancer cell line such as U2OS, HepG2, and HCT116 (19, 20) . Caspase-3 cleavage MST-1 occurs during apoptosis in mammalian cell (21) (22) (23) . In recent years, use of natural medicines has developed to reduced cisplatin-induced nephrotoxicity (24) (25) (26) . In this study, we demonstrated that cynaroside has a renoprotective effect on cisplatin-induced nephrotoxicity in mice kidneys, by attenuating degenerative changes such as less of brush border, desquamation of epithelial cells, and elevated BUN, Cre, and neutrophils in blood. Findings revealed that cisplatin-induced cell death in HK-2 cells was ameliorated by cynaroside treatment. Based on results, it was hypothesized that cynaroside treatment may be improved in cisplatin-induced nephrotoxicity. This hypothesis is supported by the following evidence: 1) Induction of caspase-3/MST-1 signaling, DNA fragmenta- tion, and mitochondrial dysfunction during apoptotic cell death was attenuated by cynaroside treatment in vitro, 2) Cisplatin-induced nephrotoxicity improved by cynaroside administration on in vivo.
Initially, we anticipated that cisplatin-induced DNA fragmentation during cell death was ameliorated by cynaroside treatment on HK-2 cells. DNA fragmentation was involved in cisplatin-induced nephrotoxicity, and was implicated in cisplatin administration in vivo (27, 28) . Cisplatin treatment in HK-2 cells induced DNA fragmentation, prevented by cynaroside treatment (Fig. 1B) , and increased DNA fragmentation induced by cisplatin administration was diminished by cynaroside administration on mice (Fig. 5B) . Apoptotic DNA fragmentation occurs during programmed cell death (apoptosis), and is a hallmark of apoptosis (29, 30) . Thus, cynaroside diminished cisplatininduced DNA fragmentation during cell death. Next, we observed that apoptotic cell death rates (apopotosis + cell death on FACS analysis) and mitochondrial dysfunction were induced by cisplatin treatment on HK-2 cells. According to recent studies, mitochondrial dysfunction increased during apoptosis process (31) . Mitochondrial membrane permeabilization may constitute apoptosis. Decrease in MMP (mitochondrial membrane potential) is a universal feature of apoptosis (32, 33) . This study confirmed measurement of apoptotic cell death ( Fig. 2A) and MMP (Fig.  2B) , rates of apoptotic cell death increased by cisplatin treatment, but is ameliorated by cynaroside pre-treatment ( Fig. 2A) . Decreased mitochondrial membrane potential induced by cisplatin recovered with pre-treatment of cynaroside on HK-2 cells (Fig. 2B) , suggesting that cynaroside may be involved in mitochondria and apoptosis process inhibiting cisplatin-induced mitochondrial dysfunction and apoptotic cell death. As previously mentioned, MST-1 is involved in cell death, and its activation requires autophosphorylation at Thr 183 and Thr 187 and caspase-3 mediated cleavage leading to initiation of DNA fragmentation and chromatin condensation (11) (12) (13) . Thus, we observed caspase-3/MST-1 signaling pathway under cisplatin-induced cell death in HK-2 cells, cisplatin treatment increased protein expression and cleaved form of MST-1, caspase-3, and autophosphorylation of MST-1 at Thr 183 and Thr
187
, but which are diminished with pre-treatment of cynaroside (Fig. 3A) . Caspase-3 activation induced by cisplatin treatment decreased by cyanroside (Fig. 3B) . Yuna, et al. reported that cisplatin-induced cell death in HCT116 a human colorectal cancer cell line, it promoted by apoptosis via MST-1 in a p53-dependent manner (19) . Results indicated that, MST-1 and caspase-3 induced by cisplatin treatment were involved in cisplatin-induced cell death in HK-2 cells. According to many reports, cisplatin-induced nephrotoxicity was associated with inflammation such as neutrophil infiltration and secretion of cytokines (16, 34) , and cisplatin administration increased creatinine (Cre) and blood urea nitrogen (BUN) in serum (35) . Thus, we observed neutrophil, Cre, and BUN in blood. Neutrophil, BUN, and Cre in blood increased by cisplatin administration, and decreased by cyanroside administration (Fig. 5A , 5B).
Cisplatin administration increased tubular damage and DNA fragmentation in kidneys, ameliorated by cynaroside administration. Park et al. (36) reported that cynaroside inhibited lipopolysaccharide-stimulated inflammatory response through NF-κB. Cynaroside has anti-cancer effect on human liver cancer cells (37) , and has protective effect against doxorubicin-induced injury through PTEN/ Akt and ERK pathway in H9c2 cells a rat myoblast (38) . Evidence supports these results, and suggests that cynaroside may be recovered cisplatin-induced nephrotoxicity via inhibiting caspase-3/MST-1 signaling pathway. In conclusion, this study found that cynaroside decreased cisplatin-induced cell death though inhibiting caspase-3/MST-1 signaling pathway in HK-2 cells, and was attenuated cisplation-induced nephrotoxicity and the elevated neutrophil, BUN, and Cre in blood. Collectively, findings suggest that cynarorside could be used to for improving cisplatininduced side effects. However, further experiments are required regarding toxicity by high dose cynaroside and caspase-3/MST-1 signaling pathway in vivo.
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